LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Kit Purifies RNA from Very Small Samples

By LabMedica International staff writers
Posted on 29 Apr 2015
Print article
The GeneChip WT Pico Kit for gene expression array target preparation from very small samples
The GeneChip WT Pico Kit for gene expression array target preparation from very small samples (Photo courtesy of )
A new kit for RNA purification prior to microarray analysis was designed specifically for small samples and for particularly difficult to isolate targets such as subpopulations of cells within larger samples like those found in heterogeneous solid tumors or hematologic malignancies.

Traditional whole-transcriptome expression analysis depends on samples derived from a relatively large number of cells. However, the gene expression measurements from these large cell populations represent an average that can often mask key differences between subpopulations. To better understand the biological significance of these differences in gene expression, researchers are increasingly focusing on smaller, characterized subsets of cells.

To accommodate these researchers Affymetrix (Santa Clara, CA, USA) developed the GeneChip WT Pico Kit for gene expression array target preparation, which can be used with as little as 100 picograms of total RNA, the amount that can be obtained from about 10 cells.

The new WT Pico Kit is compatible with small sample isolation techniques, including flow cytometry, laser capture microdissection, and fine needle aspiration. The kit prepares targets from multiple sample types, including fresh and fresh frozen tissues, cultured cells, FFPE specimens, and whole blood samples without a globin mRNA reduction step.

“In addition to conserving samples and enabling analysis of samples that may only contain small amounts of RNA, the ability to zero in on smaller sets of cells can reveal information that is hidden in larger cell populations,” said Christian Reece, product manager at Affymetrix. “Cancer researchers working with solid tumors and hematologic malignancies are particularly interested at looking at smaller and smaller groups of cells.”

Related Links:

Affymetrix


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Liquid Ready-To-Use Lp(a) Reagent
Lipoprotein (a) Reagent
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more